MTOR and Timothy syndrome: Phosphorylation levels of downstream signaling molecules protein kinase B (AKT, Ser463) and mammalian target of rapamycin (mTOR, Ser 2481 and Ser 2448) were decreased in TS cells by chromeceptin treatment (Fig. 5D).